HEALTHCOMMS_CONSULTING_LT - Accounts


Company registration number 07284813 (England and Wales)
HEALTHCOMMS CONSULTING LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022
PAGES FOR FILING WITH REGISTRAR
HEALTHCOMMS CONSULTING LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
HEALTHCOMMS CONSULTING LTD
BALANCE SHEET
AS AT 31 MARCH 2022
31 March 2022
- 1 -
2022
2021
Notes
£
£
£
£
Fixed assets
Tangible assets
4
5,757
6,158
Current assets
Debtors
5
460,027
439,590
Cash at bank and in hand
699,774
258,082
1,159,801
697,672
Creditors: amounts falling due within one year
6
(546,441)
(220,147)
Net current assets
613,360
477,525
Total assets less current liabilities
619,117
483,683
Provisions for liabilities
(981)
(752)
Net assets
618,136
482,931
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
618,036
482,831
Total equity
618,136
482,931

The notes on pages 3 to 6 form part of these financial statements.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

HEALTHCOMMS CONSULTING LTD
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2022
31 March 2022
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 23 May 2022 and are signed on its behalf by:
Sara Petela
Director
Company Registration No. 07284813
HEALTHCOMMS CONSULTING LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022
- 3 -
1
Accounting policies
Company information

Healthcomms Consulting Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 48 Rose Court, Nursery Road, Pinner, Middlesex, HA5 2AR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover
Turnover represents amounts receivable for services provided net of VAT.
1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
- 25% per annum on written down value

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

HEALTHCOMMS CONSULTING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.8
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

HEALTHCOMMS CONSULTING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
- 5 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total
12
12
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2021
14,584
Additions
2,351
Disposals
(1,479)
At 31 March 2022
15,456
Depreciation and impairment
At 1 April 2021
8,426
Depreciation charged in the year
1,919
Eliminated in respect of disposals
(646)
At 31 March 2022
9,699
Carrying amount
At 31 March 2022
5,757
At 31 March 2021
6,158
HEALTHCOMMS CONSULTING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
- 6 -
5
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
407,441
231,068
Other debtors
52,586
208,522
460,027
439,590
6
Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
20,624
28,750
Taxation and social security
127,375
82,160
Other creditors
398,442
109,237
546,441
220,147
7
Called up share capital
2022
2021
2022
2021
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
98
98
98
98
'A' OrdinaryShares of £1 each
1
1
1
1
'B' OrdinaryShares of £1 each
1
1
1
1
100
100
100
100
2022-03-312021-04-01false23 May 2022CCH SoftwareCCH Accounts Production 2022.100No description of principal activitySara PetelaD Jones072848132021-04-012022-03-31072848132022-03-31072848132021-03-3107284813core:OtherPropertyPlantEquipment2022-03-3107284813core:OtherPropertyPlantEquipment2021-03-3107284813core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3107284813core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3107284813core:CurrentFinancialInstruments2022-03-3107284813core:CurrentFinancialInstruments2021-03-3107284813core:ShareCapital2022-03-3107284813core:ShareCapital2021-03-3107284813core:RetainedEarningsAccumulatedLosses2022-03-3107284813core:RetainedEarningsAccumulatedLosses2021-03-3107284813core:ShareCapitalOrdinaryShares2022-03-3107284813core:ShareCapitalOrdinaryShares2021-03-3107284813bus:Director22021-04-012022-03-3107284813core:ComputerEquipment2021-04-012022-03-31072848132020-04-012021-03-3107284813core:OtherPropertyPlantEquipment2021-03-3107284813core:OtherPropertyPlantEquipment2021-04-012022-03-3107284813core:WithinOneYear2022-03-3107284813core:WithinOneYear2021-03-3107284813bus:PrivateLimitedCompanyLtd2021-04-012022-03-3107284813bus:SmallCompaniesRegimeForAccounts2021-04-012022-03-3107284813bus:FRS1022021-04-012022-03-3107284813bus:AuditExemptWithAccountantsReport2021-04-012022-03-3107284813bus:Director12021-04-012022-03-3107284813bus:FullAccounts2021-04-012022-03-31xbrli:purexbrli:sharesiso4217:GBP